Human epidermal growth factor receptor 2 is known to play an important role in the progression of aggressive types of breast cancer, where the corresponding ERBB2 gene is shown to be amplified in 15–20% of cases (Di Cosimo and Baselga, 2010). The gene discussed is ERBB2; the disease is breast carcinoma.